N. Pakker

发表

Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.

J. Ferro, F. Cobelens, F. van Leth, 2016, The American journal of tropical medicine and hygiene.

Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.

J. Goudsmit, M. Beld, N. Pakker, 1998, Virology.

Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status

H. Hooijkaas, K. Wolthers, R. de Groot, 2001, AIDS.

Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy.

P. Reiss, J. Kastelein, F. Wit, 2007, The Journal of infectious diseases.

HIV-1 infection as a risk factor for the development of tuberculosis: a case-control study in Tanzania.

J. Newell, M. Borgdorff, N. Pakker, 1993, International journal of epidemiology.

Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.

P. Reiss, M. D. de Jong, S. Danner, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expression

N. Pakker, R. Coutinho, P. Schellekens, 1996, Clinical and experimental immunology.

T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy.

P. Reiss, F. Wit, S. Repping, 2000, Blood.

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults

S. Khoo, P. D. de Vries, E. Katabira, 2012, The Journal of antimicrobial chemotherapy.

Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virus-infected individuals studied in relation to IL-10 and prostaglandin E2 production.

F. Miedema, N. Pakker, L. Meyaard, 1997, Blood.

A Randomized, Open‐Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral‐Naive HIV‐1‐Infected Thai Patients

S. Suwanagool, K. Ruxrungtham, D. Cooper, 2001, Journal of acquired immune deficiency syndromes.

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

P. Reiss, F. Wit, S. Danner, 2000, AIDS.

Integration of antenatal syphilis screening in an urban HIV clinic: a feasibility study

E. Katabira, Y. Manabe, N. Pakker, 2015, BMC Infectious Diseases.

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults

P. D. de Vries, E. Katabira, C. Merry, 2012, Malaria Journal.

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults

S. Khoo, P. D. de Vries, E. Katabira, 2012, The Journal of antimicrobial chemotherapy.

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation

Rob J. De Boer, John M. Leonard, Frank De Wolf, 1998, Nature Medicine.

Prognostic Markers and Immunological Reconstitution During HIV-1 Infection

N. Pakker, M. Roos, P. Schellekens, 2000 .

Temporal relationship between human immunodeficiency virus type 1 RNA levels in serum and cellular infectious load in peripheral blood.

H. Schuitemaker, A. B. van 't Wout, J. Goudsmit, 1997, The Journal of infectious diseases.

Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection.

H. Schuitemaker, F. Miedema, F. de Wolf, 1998, The Journal of infectious diseases.

Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection.

S. Danner, M. Klein, N. Pakker, 1999, Immunology Letters.

Diversity of the T‐cell receptor BV repertoire in HIV‐1‐infected patients reflects the biphasic CD4+ T‐cell repopulation kinetics during highly active antiretroviral therapy

S. Kostense, S. Danner, J. Teale, 1998, AIDS.

Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.

J. Montaner, P. Reiss, F. Wit, 1999, AIDS.

Antigen receptor function in chronic lymphocytic leukemia B cells.

R. V. van Lier, R. V. van Oers, N. Pakker, 1996, Leukemia & lymphoma.

Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. European Concerted Action on Immunological and Virological Markers of HIV Disease Progression.

G. Raab, M. Bofill, N. Pakker, 1999, Journal of immunological methods.

Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.

N. Foudraine, J. Goudsmit, S. Danner, 1999, The Journal of infectious diseases.

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection Marieke den Brinker a , Ferdinand W. N. M. Wit a ,

P. Reiss, G. Weverling, S. Danner, 2000 .

A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients.

S. Suwanagool, K. Ruxrungtham, D. Cooper, 2001 .

Kinetics of immune functions and virus replication during HIV-1 infection.

H. Schuitemaker, F. Miedema, F. de Wolf, 1997, Immunology letters.